The Company is principally engaged in next-generation sequencing concentrating on clinical applications of cancer biology, medical diagnostics products, and precision medicine for cancer prevention, treatment and monitoring.
BUSINESS
The Company intend to construct a global healthcare ecosystem to disrupt and decentralize the conventional healthcare system and improve its customers' wellbeing through comprehensive genetic and diagnostic testing.
Its current products and services are mainly targeted towards the preventive healthcare and the diagnostic testing markets. In the preventive healthcare market, the Company has been offering CircleDNA, its in-house developed consumer genetic testing service, since July 2019. The Company has expanded its products and services to diagnostic testing with the launch of COVID-19 testing services under Project Screen in April 2020, and the official launch of Circle HealthPod, a rapid detection health monitoring system for professional use and home use, in Hong Kong on November 18, 2021.
The Company manage its business by divisions, which are organized by a mixture of both business lines and geographical locations. The Company currently operates in two reporting business segments: Prevention and Diagnostics.
- Prevention: The Company provide genetics testing services to individuals and corporate entities for their employees and customers. The Company s products and services in this segment include CircleDNA and ColoClear in its pipeline.
- Diagnostics: The Company provides COVID-19 testing services to individuals, corporate clients for their employees or customers and governments for community testing. Its products and services in this segment include COVID-19 testing services under Project Screen and Circle HealthPod, a rapid detection health monitoring system that was officially launched on November 18, 2021.
HISTORY
2014 The Company was founded in 2014 and headquartered in Hong Kong.
2022
The Business Combination was consummated on May 18, 2022. As a result of the Business Combination, Artisan has become its wholly-owned subsidiary.
On May 18, 2022, Class A Ordinary Shares and Warrants commenced trading on The Nasdaq Stock Market LLC, or “NASDAQ” under the symbols “PRE” and “PRENW,” respectively.
总部
Unit 701-706, K11 Atelier King'S Road, 728 King'S Road
香港; 香港;
联系方式: 购买Prenetics Global Ltd.报告以查看信息。
EMIS公司简介是一个更大的信息服务的一部分,它结合了公司,行业和国家数据和分析在超过125个新兴市场.
请求EMIS服务的演示查看更多信息, 申请试用